QA: Lexaria Bioscience Corp in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001348362_2017_Lexaria_Bioscience_Corp.pdf

Logs

warning The stock_price does not exist industry.us_generic {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001348362, Lexaria Bioscience Corp

  xvar xval
0 AssetsCurrent 510,166
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,475
3 remainder_Assets 53,997
4 LiabilitiesCurrent 433,881
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 45,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,858
9 ResearchAndDevelopmentExpense 9,024
10 remainder_Expenses 1,297,085
11 remainder_Revenues 40,718
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 566,638
1 Liabilities 478,881
2 Expenses 1,317,967
3 Revenues 40,718
4 StockholdersEquity 87,757
5 NetIncome -1,277,249
6 ComprehensiveNetIncome -1,277,249
7 BaseVar 1,202,102
8 EconomicCapitalRatiobeforeLimitedLiability -2.08
9 EconomicCapitalRatio 0.999

Edgar->Model Mapping

Feature Distribution

Change over Time